Search

    Our Company

    Fractional Flow Reserve (FFR) Media Kit

    FFR Media Kit

    FFR is a physiological index that determines the severity of blood flow blockages in the coronary arteries and is measured using St. Jude Medical's PressureWire technology. An FFR measurement helps physicians to better identify which specific lesion or lesions are responsible for a patient's ischemia, a deficiency of blood supply to the heart caused by blood restriction.

    Credit any images and video as follows: Images or video provided courtesy of St. Jude Medical, Inc.

    News ReleasesType
    News Release - FAME II Stops Enrollment
    Independent Data Safety Monitoring Board recommends St. Jude Medical’s FAME II clinical trial stop enrollment following positive interim analysis.
    		PDF
    [50.1 KB]
    News Release - FAME Results 
    Results from the landmark FAME trial as published in the New England Journal of Medicine.    		PDF [86KB]
    News Release - FAME 2-year Follow-up Results
    St. Jude Medical announces the 2-year follow-up results form the landmark FAME (Fractional Flow Reserve (FFR) vs. Angiography in Multivessel Evaluation) trial, which found a 34% reduction in death or MI for patients whose treatment was guided by FFR.    		PDF [64KB]
    News Release - FAME II Study
    St. Jude Medical announces sponsorship of the FAME II trial to study the role of FFR in the treatment of stable coronary artery disease by comparing the clinical outcomes, safety and cost effectiveness of percutaneous coronary intervention (PCI) guided by FFR plus optimal medical treatment (OMT) to OMT alone.    		PDF
    [43 KB]
    News Release - Economic Analysis of FFR in Europe and Canada
    St. Jude Medical announces it will evaluate the cost effectiveness of an FFR-guided intervention strategy for patients with multivessel coronary artery disease in the UK, Germany, France, Italy, Switzerland, Belgium and Canada.     		PDF
    [43 KB]
    News Release - PressureWire Aeris Wireless FFR Technology 
    First use of first-to-market wireless FFR technology.    		PDF [73KB]
    News Release - PressureWire Aeris Expanded Availability
    St. Jude Medical announces a new co-marketing agreement with McKesson to offer more hospitals access to the market's only wireless FFR system.    		PDF [68KB]
    News Release - PCI Guidelines Upgrade FFR Level of Evidence
    St. Jude Medical applauds the level of evidence for FFR upgraded to an "A" following the recent results of the landmark FAME trial, which demonstrated that FFR-guided treatment improves clinical outcomes.    		PDF [72KB]
    ImagesType
    Chart showing FAME study resultsChart - FAME 2-year Follow-up Results
    The FAME Study found a  difference in patient death and myocardial infarction of 3.8% after 12 months and 4.3% after two years    		JPG [186KB]
    PressureWire CertusPhoto - PressureWire Certus
    The PressureWire Certus is the only guidewire on the market to provide a combined measurement of pressure and temperature which enables calculations of FFR, Coronary Flow Reserve (CFR) and an Index of Microcirculatory Resistance (IMR)    		JPG [99KB]
    Fact SheetsType

    FFR Fact Sheet 
    The definition and key information about FFR, including the PressureWire technology and the FAME study.

    		PDF
    [87 KB]

    Related Information

    Fractional Flow Reserve (FFR) Media Kit

    FFR Media Kit

    FFR is a physiological index that determines the severity of blood flow blockages in the coronary arteries and is measured using St. Jude Medical's PressureWire technology. An FFR measurement helps physicians to better identify which specific lesion or lesions are responsible for a patient's ischemia, a deficiency of blood supply to the heart caused by blood restriction.

    Credit any images and video as follows: Images or video provided courtesy of St. Jude Medical, Inc.

    News ReleasesType
    News Release - FAME II Stops Enrollment
    Independent Data Safety Monitoring Board recommends St. Jude Medical’s FAME II clinical trial stop enrollment following positive interim analysis.
    		PDF
    [50.1 KB]
    News Release - FAME Results 
    Results from the landmark FAME trial as published in the New England Journal of Medicine.    		PDF [86KB]
    News Release - FAME 2-year Follow-up Results
    St. Jude Medical announces the 2-year follow-up results form the landmark FAME (Fractional Flow Reserve (FFR) vs. Angiography in Multivessel Evaluation) trial, which found a 34% reduction in death or MI for patients whose treatment was guided by FFR.    		PDF [64KB]
    News Release - FAME II Study
    St. Jude Medical announces sponsorship of the FAME II trial to study the role of FFR in the treatment of stable coronary artery disease by comparing the clinical outcomes, safety and cost effectiveness of percutaneous coronary intervention (PCI) guided by FFR plus optimal medical treatment (OMT) to OMT alone.    		PDF
    [43 KB]
    News Release - Economic Analysis of FFR in Europe and Canada
    St. Jude Medical announces it will evaluate the cost effectiveness of an FFR-guided intervention strategy for patients with multivessel coronary artery disease in the UK, Germany, France, Italy, Switzerland, Belgium and Canada.     		PDF
    [43 KB]
    News Release - PressureWire Aeris Wireless FFR Technology 
    First use of first-to-market wireless FFR technology.    		PDF [73KB]
    News Release - PressureWire Aeris Expanded Availability
    St. Jude Medical announces a new co-marketing agreement with McKesson to offer more hospitals access to the market's only wireless FFR system.    		PDF [68KB]
    News Release - PCI Guidelines Upgrade FFR Level of Evidence
    St. Jude Medical applauds the level of evidence for FFR upgraded to an "A" following the recent results of the landmark FAME trial, which demonstrated that FFR-guided treatment improves clinical outcomes.    		PDF [72KB]
    ImagesType
    Chart showing FAME study resultsChart - FAME 2-year Follow-up Results
    The FAME Study found a  difference in patient death and myocardial infarction of 3.8% after 12 months and 4.3% after two years    		JPG [186KB]
    PressureWire CertusPhoto - PressureWire Certus
    The PressureWire Certus is the only guidewire on the market to provide a combined measurement of pressure and temperature which enables calculations of FFR, Coronary Flow Reserve (CFR) and an Index of Microcirculatory Resistance (IMR)    		JPG [99KB]
    Fact SheetsType

    FFR Fact Sheet 
    The definition and key information about FFR, including the PressureWire technology and the FAME study.

    		PDF
    [87 KB]

    Related Information

    ST. JUDE MEDICAL, the nine-squares symbol and MORE CONTROL. LESS RISK. are registered and unregistered trademarks and service marks of St. Jude Medical, Inc. and its related companies. ©2012 St. Jude Medical, Inc. All rights reserved.